home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Molecule That Induces Tumour Regression

  May, 17 2005 9:57
your information resource in human molecular genetics
A promising approach to eliminate cancer cells is to trigger cell death (apoptosis) with inhibitors that bind to and block anti-apoptotic proteins that help keep cancer cells alive - as reported in an advanced online publication in Nature. A newly discovered small-molecule inhibitor, called ABT-737, interferes with anti-apoptotic proteins to kill certain cancer cells directly and greatly enhance the effectiveness of chemotherapy, say the researchers.

Proteins that inhibit apoptosis, such as Bcl-XL, Bcl-2, and Bcl-w, play a role in tumour formation, growth and resistance to treatment. Stephen Fesik and colleagues used a sophisticated nuclear-magnetic-resonance-based method of identifying lead compounds to screen a library of chemicals, isolate a promising small molecule and modify it to produce ABT-737. The inhibitor binds to these anti-apoptotic proteins with an affinity two to three orders of magnitude greater than any previously reported molecule.

ABT-737 alone was found to effectively kill certain cancer cell lines, including lymphoma and small-cell lung carcinoma (SCLC) lines, and to enhance the effects of chemotherapy and radiation on other cancer cell lines. Importantly, in a mouse model, ABT-737 by itself caused complete regression of human SCLC tumour xenografts.

Author contact:

Stephen Fesik (Abbott Laboratories, Abbott Park, IL, USA)
E-mail: Stephen.Fesik@abbott.com

Online publication can be accessed by clicking here.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.